Buscar
Congreso SOLACI

Artículos del autor

Dr. Omar Tupayachi

Member of the Editorial Board of solaci.org
Coronary disease

Use of DCB in Coronary Territory: Position Document of the Academic Research Consortium

The use of drug-coated balloons (DCB) is emerging as one of the most promising strategies in coronary...
Dr. Omar Tupayachi -
Chronic Coronary Syndromes

IVUS Guided PCI: New Expansion Threshold

Intravascular ultrasound (IVUS) guided percutaneous coronary intervention (PCI) has been shown to improve clinical outcomes vs the...
Dr. Omar Tupayachi -
Arterial Accesses

Use of Distal Radial Access for Recanalization of Radial Occlusions

Transradial access (TRA) is the preferred route for most percutaneous coronary procedures, with proven benefits in reducing...
Dr. Omar Tupayachi -
Acute coronary syndromes

Use of OCT in Calcified Lesions: Results from a Subanalysis of ILUMIEN IV

Coronary calcification represents one of the main challenges in percutaneous coronary intervention (PCI), as it is associated...
Dr. Omar Tupayachi -
Chronic Coronary Syndromes

Microvascular Dysfunction in Patients with Positive Coronary CT Angiography: Implications of Invasive Physiological Studies

Both European and US clinical guidelines recommend coronary CT angiography as the starting diagnostic study when coronary...
Dr. Omar Tupayachi -
Coronary disease

Provisional Angioplasty in Left Main: What MSA Values Should We Target?

Percutaneous coronary intervention (PCI) of the unprotected left main coronary artery (LMCA) represents one of the most...
Dr. Omar Tupayachi -
Acute coronary syndromes

Flow Protocols in VA-ECMO: Impact on PCWP in Cardiogenic Shock

The use of peripheral femoro-femoral venoarterial (VA) extracorporeal membrane oxygenation (ECMO) has globally consolidated and is the...
Dr. Omar Tupayachi -
Antithrombotic Anticoagulants

ESC 2025 | HI-PRO: Extended Apixaban for Recurrence Prevention in Provoked DVT/PE

Patients with provoked venous thromboembolism (VTE) usually discontinue anticoagulation after 3 to 6 months. However, in the...
Dr. Omar Tupayachi -

SOLACI es la organización de referencia del intervencionismo cardiovascular latinoamericano.

Últimas Noticias

Transapical TMVR in High Risk Patients: Intrepid 5-Year Outcomes

Dr. Omar Tupayachi - 0
Moderate to severe mitral valve regurgitation (MR) continues is still a high prevalence condition with bad prognosis, particularly among the elderly with left ventricular...

EMERALD II: Non-Invasive Coronary Anatomy and Physiology (CCTA) in ACS Prediction

Dr. Omar Tupayachi - 0
Despite steady progress in secondary prevention and medical treatment optimization (OMT), acute coronary syndrome (ACS) remains one of the leading causes of cardiovascular morbimortality....

Impact of Balloon Post-Dilation on the Long-Term Durability of Bioprostheses after TAVR

Dr. Juan Manuel Pérez - 0
Balloon post-dilation (BPD) during transcatheter aortic valve replacement (TAVR) allows for the optimization of prosthesis expansion and the reduction of residual paravalvular aortic regurgitation....

Noticias Institucionales

SOLACI Wishes You Happy Holidays

solaci - 0
From the heart, Happy Holidays! The Latin American Society of Interventional Cardiology wishes all its members and the medical community across the continent a very Merry Christmas...

Condolences on the passing of Cristiam Arancibia

solaci - 0
The Latin American Society of Interventional Cardiology deeply mourns the passing of Lic. Cristiam Arancibia, first Director of the Chapter of Technicians and Nurses,...

Watch Again: Pulmonary Embolism in 2025 — Risk Stratification and Novel Therapeutic Approaches

solaci - 0
Our webinar “Pulmonary Embolism in 2025: Risk Stratification and Novel Therapeutic Approaches” is now available to watch. The session took place on November 25,...

Accesos

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Términos de uso -Políticas de privacidad